室性期前收缩的综合管理及治疗策略
Journal: Basic Medical Theory Research DOI: 10.32629/bmtr.v8i1.18580
Abstract
室性期前收缩是常见的心律失常,可见于健康人群和心脏病患者,严重时可诱发恶性心律失常甚至猝死。其治疗策略多样,包括生活方式干预、药物治疗(如β受体阻滞剂、抗心律失常药)、导管消融及中医药治疗。近年来,非药物疗法如迷走神经刺激、中医药联合治疗及个体化方案日益受到重视。中西医结合在增效减毒、改善长期预后方面展现出优势,但具体机制仍需深入研究。未来治疗将更注重个体化与联合策略。
Keywords
室性期前收缩;中医药;治疗;进展
Full Text
PDF - Viewed/Downloaded: 1 TimesReferences
[1] 曹克将,陈柯萍,陈明龙,等.室性心律失常中国专家共识基层版[J].实用心电学杂志,2022,31(02):77-98.
[2] Higuchi K,Bhargava M.Management of premature ventric ular complexes[J].Heart,2022,108(7):565-572.
[3] Markman T M,Nazarian S.Treatment of ventricular arrhy thmias:What's New?[J].Trends Cardiovasc Med,2019,29(5):249-261.
[4] Adams J C,Srivathsan K,Shen W K.Advances in manageme nt of premature ventricular contractions[J].J Interv Card Ele ctrophysiol,2012,35(2):137-149.
[5] Marcus G M.Evaluation and Management of Premature Ventricular Complexes[J].Circulation,2020,141(17):1404-1418.
[6] 黄一婷,曾建斌.中医药诊治室性早搏研究进展[J].亚太传统医药,2025,21(01):223-227.
[7] MarrakchiS,BadencoN,SchumacherS,etal.Focusonmalignantventricularprematurecontractions[J]. Ann Cardiol Angeiol (Paris),2023,72(5):101662.
[8] 佟腾.频发室性早搏患者临床症状差异及影响因素分析[D].东南大学,2018.
[9] Zafeiropoulos S,Coleman K,Kogan J,et al.Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Premature Ventricular Contractions:A Crossover, Randomized Clinical Tri al(NoVa-PVC)[J].JACC Clin Electrophysiol,2025,11(8):1699- 1707.
[10] Shinohara M, Fujino T, Koike H, et al. Assessment of a novel transdermal selective beta1-blocker, the bisoprolol patch, for treating frequent premature ventricular contracti ons in patients without structural heart disease[J]. J Cardiol,2017,70(3):212-219.
[11] Atici A,Sahin I,Dogan O, et al. Can the efficacy of a medical treatment be predicted based on the type of idiopat hic premature ventricular contraction?[J].J Electrocardiol, 2024,86:153782.
[12] 孙健.美托洛尔联合稳心颗粒治疗高血压心脏病伴室性期前收缩的效果观察 [J].中西医结合心血管病电子杂志,2023,11(14):27-29.
[13] 纪洪彬.美托洛尔联合稳心颗粒对老年冠心病室性期前收缩患者的效果及不良反应影响观察[J].中国现代药物应用,2025,19(08):108-111.
[14] ChenXL,Li P,Wu S J,et al.[Electrocardiographic charac teristics of idiopathic ventricular arrhythmias originating from the tricuspid annulus regions][J]. Zhonghua Xin Xue Guan Bing Za Zhi,2018,46(8):611-616.
[15] Li H,Liu A,Liu Z,et al. Evaluation of the effectiveness and safety of acupuncture in the treatment of premature ventricular contractions: A protocol for systematic review and meta-analysis[J].Medicine (Baltimore),2021,100(44):e27697.
[16] 雷亚强.莫雷西嗪结合美托洛尔对室性心律失常患者心率变异性及不良反应的影响[J].北方药学,2020,17(07):167-168.
[17] HutchingsD C,Denton C P,Venetucci L,et al.Suppressi on of premature ventricular complexes with the PDE5 inhibitor sildenafil:First clinical experience[J].Exp Physiol,2025.
[18] Zhong L, Lee Y H, Huang X M, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating prem ature ventricular contractions: a single-center retrospective study[J]. Heart Rhythm,2014,11(2):187-193.
[19] Diaz I E,Cozar L R,Borrego I,et al.[Ablation of prema ture ventricular contractions originating in the right ventri cular outflow tract using non-contact mapping][J].Rev Esp Cardiol,2011,64(12):1198-1201.
[20] Khalaph M,Costard-Jackle A, Braun M, et al. Successful ablation of Purkinje ectopy-triggered ventricular fibrillat ion storm in a patient with orthotopic heart transplantation and severe SARS-CoV-2 pneumonia: a case report[J].Eur Heart J Case Rep,2024,8(2):ytae057.
[21] Huang J, Zhao Y, Yang L, et al. Clinical observation of radiofrequency ablation for premature ventricular contracti ons originating from uncommon His-Purkinje sites[J].J Interv Card Electrophysiol,2023,66(5):1185-1191.
[22] Ariizumi K,Hashimoto R,Hasuda N,et al.Surgical cryoab lation for frequent premature ventricular contraction origin ating in the left sinus of Valsalva[J].Jpn J Thorac Cardiovasc Surg,2000,48(11):730-732.
[23] Cheilas V,Dritsas A,Martinos A,et al.Impact of Cathet er Ablation on Functional Capacity and Cardiac Stress Markers in Patients with Premature Ventricular Contractions[J]. Med Sci(Basel),2025,13(3).
[24] Liu M, Long X, Xu J, et al. Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs[J].Pharmacol Res,2022,185:106515.
[2] Higuchi K,Bhargava M.Management of premature ventric ular complexes[J].Heart,2022,108(7):565-572.
[3] Markman T M,Nazarian S.Treatment of ventricular arrhy thmias:What's New?[J].Trends Cardiovasc Med,2019,29(5):249-261.
[4] Adams J C,Srivathsan K,Shen W K.Advances in manageme nt of premature ventricular contractions[J].J Interv Card Ele ctrophysiol,2012,35(2):137-149.
[5] Marcus G M.Evaluation and Management of Premature Ventricular Complexes[J].Circulation,2020,141(17):1404-1418.
[6] 黄一婷,曾建斌.中医药诊治室性早搏研究进展[J].亚太传统医药,2025,21(01):223-227.
[7] MarrakchiS,BadencoN,SchumacherS,etal.Focusonmalignantventricularprematurecontractions[J]. Ann Cardiol Angeiol (Paris),2023,72(5):101662.
[8] 佟腾.频发室性早搏患者临床症状差异及影响因素分析[D].东南大学,2018.
[9] Zafeiropoulos S,Coleman K,Kogan J,et al.Transcutaneous Electrical Vagus Nerve Stimulation to Suppress Premature Ventricular Contractions:A Crossover, Randomized Clinical Tri al(NoVa-PVC)[J].JACC Clin Electrophysiol,2025,11(8):1699- 1707.
[10] Shinohara M, Fujino T, Koike H, et al. Assessment of a novel transdermal selective beta1-blocker, the bisoprolol patch, for treating frequent premature ventricular contracti ons in patients without structural heart disease[J]. J Cardiol,2017,70(3):212-219.
[11] Atici A,Sahin I,Dogan O, et al. Can the efficacy of a medical treatment be predicted based on the type of idiopat hic premature ventricular contraction?[J].J Electrocardiol, 2024,86:153782.
[12] 孙健.美托洛尔联合稳心颗粒治疗高血压心脏病伴室性期前收缩的效果观察 [J].中西医结合心血管病电子杂志,2023,11(14):27-29.
[13] 纪洪彬.美托洛尔联合稳心颗粒对老年冠心病室性期前收缩患者的效果及不良反应影响观察[J].中国现代药物应用,2025,19(08):108-111.
[14] ChenXL,Li P,Wu S J,et al.[Electrocardiographic charac teristics of idiopathic ventricular arrhythmias originating from the tricuspid annulus regions][J]. Zhonghua Xin Xue Guan Bing Za Zhi,2018,46(8):611-616.
[15] Li H,Liu A,Liu Z,et al. Evaluation of the effectiveness and safety of acupuncture in the treatment of premature ventricular contractions: A protocol for systematic review and meta-analysis[J].Medicine (Baltimore),2021,100(44):e27697.
[16] 雷亚强.莫雷西嗪结合美托洛尔对室性心律失常患者心率变异性及不良反应的影响[J].北方药学,2020,17(07):167-168.
[17] HutchingsD C,Denton C P,Venetucci L,et al.Suppressi on of premature ventricular complexes with the PDE5 inhibitor sildenafil:First clinical experience[J].Exp Physiol,2025.
[18] Zhong L, Lee Y H, Huang X M, et al. Relative efficacy of catheter ablation vs antiarrhythmic drugs in treating prem ature ventricular contractions: a single-center retrospective study[J]. Heart Rhythm,2014,11(2):187-193.
[19] Diaz I E,Cozar L R,Borrego I,et al.[Ablation of prema ture ventricular contractions originating in the right ventri cular outflow tract using non-contact mapping][J].Rev Esp Cardiol,2011,64(12):1198-1201.
[20] Khalaph M,Costard-Jackle A, Braun M, et al. Successful ablation of Purkinje ectopy-triggered ventricular fibrillat ion storm in a patient with orthotopic heart transplantation and severe SARS-CoV-2 pneumonia: a case report[J].Eur Heart J Case Rep,2024,8(2):ytae057.
[21] Huang J, Zhao Y, Yang L, et al. Clinical observation of radiofrequency ablation for premature ventricular contracti ons originating from uncommon His-Purkinje sites[J].J Interv Card Electrophysiol,2023,66(5):1185-1191.
[22] Ariizumi K,Hashimoto R,Hasuda N,et al.Surgical cryoab lation for frequent premature ventricular contraction origin ating in the left sinus of Valsalva[J].Jpn J Thorac Cardiovasc Surg,2000,48(11):730-732.
[23] Cheilas V,Dritsas A,Martinos A,et al.Impact of Cathet er Ablation on Functional Capacity and Cardiac Stress Markers in Patients with Premature Ventricular Contractions[J]. Med Sci(Basel),2025,13(3).
[24] Liu M, Long X, Xu J, et al. Hypertensive heart disease and myocardial fibrosis: How traditional Chinese medicine can help addressing unmet therapeutical needs[J].Pharmacol Res,2022,185:106515.
Copyright © 2026 秀芝, 郑冉, 丛岩, 李铭, 席迎春, 万全
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
